Leonard Brabson
Obstetrics & Gynecology · Powell, TNNPI 1689736431
Payments from drug & device makers
Across 110 payments — averaging $15.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$604
- Hologic Sales And Service, LLC$230
- Mayne Pharma Commercial LLC$133
- Therapeuticsmd, Inc.$102
- Sage Therapeutics, LLC$101
- Astellas Pharma US Inc$82
- plus $500 from 14 others
What the payments were for
- Food & beverage$1,749100%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $604 |
| Hologic Sales And Service, LLC | 16 | $230 |
| Mayne Pharma Commercial LLC | 9 | $133 |
| Therapeuticsmd, Inc. | 8 | $102 |
| Sage Therapeutics, LLC | 6 | $101 |
| Astellas Pharma US Inc | 5 | $82 |
| Agile Therapeutics, Inc. | 5 | $79 |
| Innovation Technologies Inc | 1 | $77 |
| Myovant Sciences Inc. | 3 | $57 |
| Exeltis, USA Inc. | 3 | $54 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Coopersurgical, Inc. | 2 | $38 |
| Pfizer | 2 | $37 |
| Mylan Pharmaceuticals Inc. | 2 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Covidien LP | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Shield Therapeutics Inc | 1 | $14 |
| Sanara Medtech Inc. | 1 | $13 |
| Organon | 1 | $13 |
How this compares
$1,752 in reported general payments places this provider in the 60th percentile of 763 obstetrics & gynecology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 346 | $22,340 |
| Estradiol (Twice Weekly)Estradiol | 31 | $3,044 |
| ProgesteroneProgesterone, Micronized | 45 | $1,746 |
| Clobetasol Propionate | 37 | $1,704 |
| LyllanaEstradiol | 18 | $1,381 |
| DottiEstradiol | 16 | $1,154 |
| FyavolvNorethindrone Ac/Eth Estradiol | 13 | $1,057 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 20 | $347 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 23 | $345 |
| Amitriptyline Hcl | 15 | $250 |
| Levothyroxine Sodium | 29 | $189 |
| Betamethasone Valerate | 11 | $127 |
| Fluconazole | 38 | $115 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Powell
- Daniel HarnsbergerChattanooga$2.5M
- Benjamin ChappellMemphis$1.2M
- Grover MayJohnson City$916K
- John GreenElizabethton$878K
- Samuel SimhaMemphis$536K
- Brent LaingElizabethton$480K
- David BarkerChattanooga$446K
- Lolly EldridgeJackson$353K
- Larry FieldsKnoxville$323K
- Stephen HammondJackson$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.